Pharma OXY 50 Ampoules

Pharma OXY 50 Ampoules

  • Brand: Pharmacom Labs
  • Product Code: Pharma OXY 50 Ampoules
  • Availability: In Stock
  • $45.00



ACTIVE HALF-LIFE 8-9 hours
CLASSIFICATION Anabolic Steroid
DOSAGE Men: 250-350 mg/week
ACNE Yes
WATER RETENTION High
HBR Possible
HEPATOTOXICITY Yes
AROMATIZATION No
CARRIER OIL Grapeseed Oil
MANUFACTURER Pharmacom Labs
LAB TEST See Document
WAREHOUSE International Warehouse 3
SUBSTANCE Oxymetholone Injectable

Discover the power of Oxymetholone, widely known as Anapolon or Anadrol?a potent synthetic anabolic steroid originally designed to combat osteoporosis and anemia while promoting muscle growth in those suffering from malnutrition. Approved by the FDA for human use, Oxymetholone's popularity waned after the development of non-steroidal alternatives, leading to its discontinuation by manufacturers like Syntex in 1993.

This powerhouse steroid is often likened to methandienone in its capability to induce significant muscle gains and enhance strength. However, it's crucial to note that much of the weight increase is attributed to water retention, which may elevate blood pressure during cycles.

Oxymetholone's unique properties boost hemoglobin levels and increase blood volume, delivering a remarkable ?pump? effect for athletes. Be aware, though, that this can lead to muscle soreness soon after intense workouts.

As a derivative of dihydrotestosterone, Oxymetholone does not aromatize into estrogen. While it doesn?t convert directly to estradiol, it does exhibit estrogen-like effects. To combat these effects, only antiestrogens are effective, as aromatase inhibitors do not work in this case.

Some users speculate that these estrogenic characteristics may stem from progestogenic activity akin to nandrolones; however, research confirms that Oxymetholone does not possess progestogenic properties.

Pharmacom Labs has developed an injectable formulation of Oxymetholone, ensuring improved bioavailability and reduced hepatotoxicity when compared to oral versions?thanks to the elimination of first-pass liver metabolism.